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Inducible Nonlymphoid Expression of Fas Ligand
Is Responsible for Superantigen-Induced
Peripheral Deletion of T Cells
Brunner et al., 1995; Dhein et al., 1995; Ju et al., 1995),
which is believed to be one mechanism underlying pe-
ripheral deletion. Mice or humans lacking functional Fas
or FasL (Watanabe-Fukunaga et al., 1992; Fisher et al.,
1995; Rieux-Laucat et al., 1995) display profound lym-
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sues from the immune response (Hahne et al., 1996;
Stuart et al., 1997). These studies prompted us to exam-
ine the role of nonlymphoid FasL in the phenomenon ofSummary
peripheral deletion with the idea that FasL expressed
outside the lymphoid compartment might have a moreFas (CD95) and Fas ligand (FasL) play major roles in
general role in controlling immune reactions.staphylococcal enterotoxin B (SEB)±induced periph-
eral deletion of Vb81 T cells. We found that peripheral
deletion was defective in radiation chimeras with non- Results and Discussion
functional tissue FasL, regardless of the FasL status
of the bone marrow±derived cells. SEB induced a dra- We employed a well-characterized system wherein Vb81
matic upregulation of FasL expression and function in T cells are deleted in response to a superantigen, SEB
nonlymphoid cells of liver and small intestine. This (Kawaba and Ochi, 1991). SEB induces expansion and
effect was resistant to inhibition by cyclosporin A, peripheral deletion by binding to MHC class II molecules
which also failed to inhibit peripheral deletion. In SCID of antigen-presenting cells where it is presented to most
animals nonlymphoid tissues did not express FasL in Vb81 T cells without a processing requirement (White
response to SEB unless transplanted lymphocytes et al., 1989). To further examine the role of FasL in pe-
were present. Thus, some immune responses induce ripheral deletion, we used mice defective in expression
FasL in nonlymphoid tissues, which in turn kills acti- or function of Fas (lpr) and FasL (gld) (Takahashi et al.,
vated lymphocytes, leading to peripheral T cell de- 1994). In the experiment shown in Figure 1, SEB induced
letion. the expansion of Vb81 T cells in wild-type (wt) animals,
followed by deletion. This Vb81 T cell deletion was not
Introduction observed in the FasL-defective gld mice where Vb81 T
cells continued to expand throughout the course of the
The apoptotic death of effector T cells following stimula- experiment. These observations confirm that Fas/FasL
tion by a strong antigenic challenge (peripheral deletion) interactions participate in peripheral deletion of Vb81 T
is one of the major regulatory mechanisms maintaining cells induced by SEB.
immune homeostasis. T cells respond to antigen by ex- We then examined this phenomenon in bone marrow
panding in numbers (as predicted by clonal selection), chimeric animals, in which lethally irradiated wt or gld
and after a period of days these numbers decline, often mice were reconstituted with bone marrow from wt or
to below the original levels via an apoptotic process gld donors. Six to eight weeks after reconstitution, mice
(Kawabe and Ochi, 1991). One mechanism by which this were challenged with SEB, and the pattern of T cell
apoptotic deletion occurs is via expression of Fas (CD95) expansion or deletion in the peripheral blood was ana-
and Fas ligand (FasL, CD95L), as peripheral deletion is lyzed. In the experiment shown in Figure 1, irradiated
partially defective in animals lacking Fas (Singer and wt mice reconstituted with gld bone marrow (gld→wt)
Abbas, 1994; Mogil et al., 1995). In vitro, T cell activation displayed an expansion of Vb81 T cells followed by the
results in coexpression of both Fas and its ligand, re- peripheral deletion characteristic of wt mice. Peripheral
sulting in ªsuicideº of the cells (Alderson et al., 1995; deletion was not prevented by the defect in FasL on
bone marrow±derived cells. In striking contrast, wt→gld
mice showed an absence of peripheral deletion, dis-‖ To whom correspondence should be addressed (e-mail: dgreen
5240@aol.com). playing a pattern similar to that of gld mice (Figure 1A).
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Figure 1. Vb81 T Cell Peripheral Deletion Is
Deficient in Mice Lacking Functional Periph-
eral FasL
Vb81 T cell deletion was induced by SEB in-
jection of C57BL/6J wt and gld mice and of
C57BL/6J bone marrow chimeras (gld→wt ir-
radiated wt host reconstituted with gld bone
marrow; wt→gld, irradiated gld host reconsti-
tuted with wt bone marrow). (A) The percent-
age of Vb61 T cells was determined as a con-
trol (B). At the times indicated, T cells were
isolated from peripheral blood. FACS analysis
was used to determine the number of Vb81
and Vb61 T cells in peripheral blood, counted
as a percent of the total CD31 T cells. Data
are mean and standard deviation of values
from five mice for each group, and the results
are representative of three independent ex-
periments. Similar effects were observed in
experiments performed on the C3H back-
ground (data not shown).
In some groups the percentage of Vb61 T cells was also these tissues by performing the experiments shown in
Figures 4A and 4B. Liver cells were dissociated anddetermined during the course of the experiment (Figure
1B). The results showed that the expansion and deletion stained with antibodies to FasL. As expected, some of
the FasL1 cells seen following administration of SEBin response to SEB was specific to the Vb81 subset.
Similar results were obtained in three additional experi- were CD31 T cells. Notably, however, at least half of the
FasL1 cells were negative for CD3 (CD32) (Figure 4A,ments. Thus, while functional FasL appears to partici-
pate in peripheral deletion, its functional expression in left panel). Using MAC-1 (CD11b) as a marker for macro-
phages (e.g., Kupffer cells) and fibroblasts (Springer etperipheral nonlymphoid tissues rather than the T cell
compartment appears to be the predominant factor in
this process. To confirm these results, chimeras were
constructed in which gld bone marrow was transplanted
into irradiated lpr mice (gld→lpr). In these animals nor-
mal FasL is expressed in the parenchymal tissues, but
without Fas. The bone marrow±derived cells have defec-
tive FasL but normal Fas. Thus, while neither animal is
capable of normal peripheral deletion (Figure 1A; Singer
and Abbas, 1994; Mogil et al., 1995), the SEB-induced
deletion of Vb81 T cells in the chimera was indistinguish-
able from that of wt mice.
Although some tissues are known to constitutively
express FasL (Bellgrau et al., 1995; Griffith et al., 1995;
French et al., 1996, 1997; Lu et al., 1997), it was possible
that some might only express it following superanti-
gen administration. Therefore, to determine which non-
lymphoid tissues might be involved in T cell deletion,
we screened several tissues for FasL mRNA expression
using RT±PCR at 3, 6, and 9 days after SEB administra-
tion. We found that within 3 days of SEB injection, FasL
was inducibly expressed in spleen (as expected), as
well as lung, liver, and small intestine (Figure 2). Large
intestine and brain were negative.
Since this approach did not discriminate between
lymphoid and nonlymphoid FasL, we then employed in
situ hybridization to examine the pattern of expression
following SEB injection. As shown in Figure 3, small
intestine and liver expressed a significant amount of
Figure 2. RT±PCR Analysis of FasL mRNA Expression in Organs ofFasL mRNA 3 days after exposure to the superantigen.
SEB-Treated and Untreated Mice
This was especially dramatic in the small intestine,
Liver, small intestine, large intestine, lung, brain, and spleen werewhere its location on the epithelia and lamina propria
assayed for FasL. Assessment of b-actin mRNA was used as a
was evident (Figure 3E). Lung was not examined by in control and to titrate the amount of cDNA loaded. Three different
situ hybridization for technical reasons. dilutions were used (1:10, 1:100, 1:1000). Results are representative
of three independent experiments.We further characterized the upregulation of FasL in
Tissue FasL Mediates Peripheral T Cell Deletion
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Figure 3. Detection of FasL mRNA in Non-
lymphoid Tissues after SEB Challenge
In situ hybridization of FasL mRNA expres-
sion in the liver (A and B) and small intestine
(D and E). Animals were untreated (A and D)
or used 3 days after SEB challenge (B and
E). Hematoxylin (H) staining of the corre-
sponding antisense probe for FasL mRNA de-
tection from the SEB-treated animals is also
shown (C and F). A FasL sense probe for four
specimens showed negligible endogenous
hybridization (data not shown).
al., 1979; Beller et al., 1982), we found that most Mac- by treatment of the mice with CsA (Figure 4B), similar
to the lack of effect on inducible FasL expression in11 cells in the liver became FasL1 following SEB admin-
istration (Figure 4A, center). Interestingly, in the experi- Mac-11 liver cells (Figure 4A).
In contrast, FasL expression on SEB-activated spleenment shown in the right panel of Figure 4A, we found
that the induced expression of FasL was not inhibited cells was sensitive to inhibition by CsA in vivo. Spleen
cells from SEB-treated mice were potent killers of Fas1by treatment of the animals with cyclosporin A (CsA)
(see below). These observations of inducible FasL in the target cells either ex vivo (data not shown) or following
restimulation with anti-CD3 (Figure 4C). At an effectorliver are consistent with an earlier study showing that
the liver is an important site for peripheral deletion of to target cell ratio of 6.5 to 1, in vivo activated and
restimulated spleen cells induced greater than 50% DNAexogenous antigen-responsive T lymphocytes (Huang
et al., 1994). Our findings suggest that this may be a fragmentation in Fas1 target cells. However, FasL func-
tion on restimulated SEB-induced splenic T cells wasmanifestation of inducible FasL expression and its inter-
action with activated Fas1 T cells in the liver. suppressed by in vivo administration of CsA (Figure 4C).
Thus, CsA inhibits the priming of splenocytes for FasLTo evaluate the function of nonlymphoid FasL, we
isolated intestinal epithelial cells (IEC) from SEB-treated expression by SEB, but not SEB-induced expression of
functional FasL on other, nonlymphoid cell types.and untreated animals and tested their ability to kill Fas1
target cells (Brunner et al., 1996). These epithelial prepa- The failure of CsA to suppress functional FasL on
intestinal epithelium is consistent with a role of non-rations contained less than 1% T cells, as detected using
antibodies to CD3, TCRb, and TCRd (data not shown). lymphoid FasL in peripheral deletion, as CsA does not
inhibit either Fas-mediated death or peripheral deletionAs shown in Figure 4B, intestinal epithelial cells from
SEB-treated but not untreated animals effectively killed (Gonzalo et al., 1992; Vanier and Proud'Homme, 1992;
Kuschnaroff et al., 1997). We confirmed these results intargets bearing Fas, but not the Fas2 parental line (Fig-
ure 4B). Thus, the FasL induced on intestinal epithelium the experiment shown in Figure 4D. Administration of
CsA failed to interfere with peripheral deletion of Vb81by in vivo administration of SEB is functional. Interest-
ingly, this effect of SEB administration was not inhibited T cells in response to SEB. Recently Latinis et al. (1997)
Immunity
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Figure 4. Detection of FasL Upregulation on
Nonlymphoid and Lymphoid Cells
(A) FACS analysis of freshly dissociated liver
cells double stained with anti-CD3-FITC or
anti-MAC-1-FITC and anti-FasL-PE. FasL ex-
pression on CD32 cells (left), MAC-11 cells
(center and right) in liver from untreated mice
(thin black line, left and center panels), three
days after SEB treatment (solid black line), or
three days after injection of CsA plus SEB
(thin black line, right panel) are shown, as well
as isotype matched PE-conjugated antibody
(dotted black line). Twenty thousand cells/
sample were assessed. The results are repre-
sentative of three independent experiments.
(B) Epithelial cells from the small intestine of
SEB-treated mice have functional FasL. BALB/
cBy mice were challenged in vivo with SEB,
and epithelial cells were prepared. These
were cocultured with previously 3H-TdR-
labeled L1210 or L1210-Fas target cells for
18 hr (E:T ratio, 20:1). Induction of apoptosis
in the targets was assessed as percent DNA
fragmentation.
(C) FasL function on SEB-stimulated spleen
cells. Splenocytes from animals treated in
vivo with SEB and/or CsA were cocultured
with L1210-Fas cells at the indicated ratios
in anti-CD3-coated plates. Target cell DNA
fragmentation was determined after 18 hr.
The experiment shown is representative of
three independent experiments.
(D) SEB-induced peripheral deletion of Vb81
T cells in CsA-treated animals. The percent-
age of Vb81 T cells was analyzed after CsA
and/or SEB treatment in C3H mice (five mice/
group). The results shown are representative
of two independent experiments.
found that while NF-AT activation (which can be blocked suggesting a requirement for cell±cell interactions (i.e.,
ªfratricideº). Similarly, activation of murine T cell blastsby CsA) is required for FasL promoter activation in T
cells, it is not required for activity of this promoter in only led to apoptosis when the cells were cultured at
higher densities, permitting such fratricide (Figure 5A).a nonlymphoid tissue, testicular sertoli cells. Similarly,
inducible nonlymphoid expression of FasL appears to As a control, both 2B4 and murine T cell blasts under-
went apoptosis in response to other agents (dexametha-be resistant to the effects of CsA.
Our results suggest that peripheral deletion of Vb81 sone, etoposide) in a density-independent fashion (data
not shown). These results are representative of five inde-T cells in response to SEB is predominantly dependent
upon inducible expression of FasL on nonlymphoid pendent experiments.
In vivo, contact between activated T lymphocytes maycells. However, we and others (Brunner et al., 1995;
Dhein et al., 1995) have previously shown that activation- be limited. As another approach toward evaluating the
requirement for fratricide during AICD, we cultured Tinduced cell death (AICD) in transformed T cells can
proceed via cell autonomous Fas/FasL interactions. cells in increasing concentrations of dextran to reduce
cell contact as the media became more viscous. ThisThat is, activated T cells can commit suicide. Why, then,
do T cells in vivo fail to undergo this suicide (e.g., in approach has been described previously (Martz, 1975).
AICD in A1.1 cells proceeded independently of dextranwt→gld chimeras; Figure 1A)?
To address this question, we reexamined the phenom- concentration (Figure 5B), as did apoptosis induced by
other agents (dexamethasone, etoposide) in 2B4 andenon of activation-induced apoptosis in transformed
and nontransformed T cells. In the experiments shown murine T cell blasts (data not shown). However, AICD
in the latter cells was effectively inhibited at higher dex-in Figure 5A, we activated T cells at different densities
and measured AICD. As we had previously observed, tran concentrations. These results are representative of
three independent experiments. Therefore, unlike A1.1A1.1 T cells underwent AICD in a density-independent
manner (Brunner et al., 1995). In contrast, another T cell T cells, nontransformed T cells are more efficiently killed
by FasL on another cell than on their own surface.hybridoma, 2B4, failed to undergo AICD at low density,
Tissue FasL Mediates Peripheral T Cell Deletion
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Figure 5. Cell Contact Dependence of Acti-
vation-Induced Cell Death in Mouse T Cell
Hybridomas and Blasts
Cell death was assessed by propidium iodide
staining after 18 hr.
(A) Cell density dependence of death induced
by anti-CD3 in the T cell hybridomas A1.1
(filled circles) and 2B4 (filled squares) and in
mouse T cell blasts (filled triangles).
(B) Effects on activation-induced cell death
of viscous dextran in the cell culture medium
of A1.1 (filled circles), 2B4 (filled squares), and
mouse T cell blasts (filled triangles) in anti-
CD3-coated plates. Control cells were treated
with hamster IgG.
It is unclear why AICD in A1.1 (Brunner et al., 1995) response (e.g., via an effect of SEB-induced T cells).
Therefore, we examined the effects of SEB administra-and in Jurkat T cells (Dhein et al., 1995) proceeds in a
cell autonomous manner, while AICD in nontransformed tion on FasL expression in mice carrying the SCID muta-
tion. As shown in Figure 6, in situ hybridization failed tomurine T cells (and transformed 2B4 cells) does not. It
is possible, though, that in the transformed cells in vitro, detect significant levels of FasL mRNA expression in
the livers or intestines of SEB-treated SCID animals.folding or blebbing of the membrane allows presentation
of functional FasL to Fas on the same cell, and that This absence of FasL expression was confirmed by RT±
PCR of liver and small intestine in these mice (data notthis effect does not efficiently proceed in normal T cell
blasts. shown). However, when SCID mice were reconstituted
with splenic lymphocytes (4 3 107) from wt donors, SEBIf FasL responsible for peripheral deletion comes from
cells other than the activated T cell (as our data suggest), effectively induced FasL expression in the peripheral
tissues. In the latter case, the expression of FasL onthen specificity must come from another aspect of T cell
activation. One role for T cell activation during peripheral nonlymphoid cells (e.g., epithelia) was readily apparent.
Therefore, the expression of FasL on peripheral tissuesdeletion might therefore be the generation of suscepti-
bility to Fas-mediated apoptosis, which would ensure in response to superantigen is dependent on the pres-
ence of responsive lymphocytes.that only activated T cells die upon contact with non-
lymphoid FasL. Susceptibility to Fas-mediated apopto- A more formal demonstration that SEB-activated T
cells induce FasL expression in SCID mice is providedsis is induced by T cell activation (Klas et al., 1993;
Brunner et al., 1996; Refaeli et al., 1998). by the experiment shown in Figure 7A. SCID mice were
reconstituted with wt or gld splenocytes and then in-We suspected that T cell activation also plays another
role in the process of peripheral deletion, in that acti- jected with SEB. Three days later, IEC were isolated and
tested for functional FasL expression. IEC from SEB-vated T cells may induce nonlymphoid FasL expression.
The ability of SEB to induce FasL expression in periph- injected SCID mice failed to kill Fas1 target cells, unless
the animals were reconstituted with splenocytes. How-eral tissues might either be a direct effect of the entero-
toxin or might occur as a consequence of the immune ever, the ability of the splenocytes to express function
Immunity
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Figure 6. Functional Lymphocytes Are Required for SEB-Induced FasL mRNA Expression in Nonlymphoid Tissues
Three-week-old C3HSmn.CPrkdeSCID mice were injected with 75 mg SEB, and tissues were analyzed by in situ hybridization with antisense
FasL riboprobe as in Figure 3. Liver (A and C) and small intestine (E and G) of SCID mice (A and E) or SCID mice reconstituted with 4 3 107
spleen cells (C, D, G, and H) 3 days after SEB treatment are shown. Hematoxylin staining (B, D, F, and H) of the respective dark fields is also
shown.
FasL was irrelevant; gld and wt splenocytes were equally Here, we have demonstrated that other nonlymphoid
tissues, which perhaps should not express constitutiveeffective for inducing functional FasL on epithelial cells.
Consistent with this is the observation that Vb81 T cells FasL due to their high visibility to the lymphoid system,
can do so in response to an intensive cellular immunein SCID mice reconstituted with wt or gld splenocytes
showed the same pattern of expansion and deletion reaction. Our observations lead to a model of lympho-
cyte±periphery interactions in which the extent of anfollowing administration of SEB (Figure 7B). As a control,
the percentage of Vb61 T cells was also determined immune response regulates FasL expression in some
tissues, which in turn induces lymphocyte apoptosisduring the course of the experiment, and this population
did not undergo SEB-induced deletion (data not shown). and reduces the numbers of responding cells. This might
function as a form of conditional immune privilege, inFasL expressed constitutively on nonlymphoid tis-
sues can play a role in immune regulation. Indeed, im- which a tissue effectively dictates, via inducible FasL
expression, the degree of inflammation it will allow. Dif-mune privilege in the anterior chamber of the eye is
dependent on functional FasL in the parenchymal cells ferent tissues may form a continuum, from constitutively
privileged tissues (the eye) where responses are almostof this organ (Griffith et al., 1995, 1996). FasL on testicu-
lar sertoli cells has also been suggested to protect these never permitted, to inducible tissues (liver, intestine?),
to perhaps some tissues that never express FasL andcells upon transplantation (Bellgrau et al., 1995), al-
though this is controversial (Allison et al., 1997). More- tolerate any amount of immunological damage. Thus,
each tissue monitors the extent of local response andover, FasL on cornea functions to prevent allogeneic
rejection of this tissue (Stuart et al., 1997), and expres- expresses FasL when a critical threshold is reached.
This monitoring might involve cytokine release from re-sion of the ligand on a murine melanoma line functions
to prevent rejection of the tumor (Hahne et al., 1996). sponding T cells, most likely one that is not inhibited by
CsA (based on the results shown in Figure 4). There areDuring viral infections in the eye, as well as during cor-
neal allograft acceptance, inhibition of immune responses several cytokines for which production by T cells can
be partially or completely resistant to CsA, includingcorresponds to induction of apoptosis in infiltrating cells
(Griffith et al., 1996; Stuart et al., 1997). Thus, non- IL-5, IL-10, IL-13, and TGFb (Rao et al., 1997). Whether
these or other cytokines might be involved in the induc-lymphoid FasL is capable of inducing apoptosis in infil-
trating T cells, thereby minimizing potential tissue dam- tion of nonlymphoid FasL expression by T cells in vivo
has not yet been examined.age as a consequence of inflammation.
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in deletion of superantigen-responsive T cells in vivo,
they do not rule out the possibility that other molecules
are similarly involved in this process. For example, tumor
necrosis factor has been shown to play an important
role, together with FasL, in T cell peripheral deletion
(Sytwu et al., 1996). Other members of this ligand family
might also function to induce T cell apoptosis (e.g.,
TRAIL/APO-2L) (Wiley et al., 1995); however, the exact
role of these ligands awaits a more precise definition of
their function in vivo.
In any case, FasL-mediated apoptosis is clearly com-
plex. For example, one recent study has noted that mac-
rophages expressing FasL intracellularly do not kill tar-
gets unless they receive a signal to induce the release
of the FasL (Tsutsui et al., 1996). We have similarly noted
that some FasL1 tumor lines fail to kill Fas1 targets (T. B.,
unpublished observations).
Our results support the idea that expression of FasL
in response to lymphocyte reactivity plays an important
role in regulating T cell expansion via peripheral deletion.
If so, then those conditions under which inflammation
is favored (rather than FasL-induced apoptosis) may
contribute to direct bystander tissue damage by immune
responses. This might result in disease states such as
autoimmunity, graft rejection, and graft versus host re-
sponses. However, recent studies have shown that
apoptosis of lymphoid cells can lead directly to the in-
duction of immune tolerance (Griffith et al., 1996). This
tolerance is not merely deletion but the result of a Th2-
dominated immune deviation. Thus, immune responses
that might lead to tissue damage and/or autoimmunity
can be controlled by induction of apoptosis and by a
subsequent regulatory immune reaction, triggered by a
response to the apoptotic T cells. Therefore, lymphoid±
parenchymal interactions centering on FasL (and per-
haps related molecules) may play pivotal roles in the
Figure 7. SEB-Activated T Cells Induce FasL Expression on Periph- regulation of the immune response.
eral Nonlymphoid Tissues
(A) C3HSmn.CPrkdeSCID mice were transplanted with 4±5 3 107 Experimental Procedures
splenocytes from gld mice and 48 hr later were challenged in vivo
with SEB. Epithelial cells (IEC) were prepared and cocultured with Reagents, Animals, and Treatments
previously 3H-TdR-labeled L1210 or L1210-Fas target cells for 18 The following reagents were used for this study: CsA and SEB
hr (ratio 20:1). As a control IEC from gld mice SEB-treated or not (Sigma Chemical Co.), [3H]thymidine, and 32P (NEN).
treated were collected. Induction of apoptosis in the target cells BALB/cBy, C3H, C57BL/6J, and C3HSmn.CPrkdeSCID mice were
was assessed as percent DNA fragmentation. purchased from Jackson Laboratories. The animals were treated in
(B) SEB induces peripheral Vb81 T cell deletion in SCID mice recon- vivo with SEB and/or CsA injected intravenously and intraperitone-
stituted with wt or gld splenocytes. SCID mice were transplanted ally, respectively. SEB was solubilized in distilled water, CsA in
with spleen cells from gld or wt mice of the same background 90% light mineral oil and 10% ethanol. The dose of SEB producing
strain and challenged with SEB (three mice/group). These results optimal deletion of Vb81 T cells was determined in each mouse
are representative of two independent experiments. strain to be as follows: BALB/cBy (75 mg/20 g mouse), C3H and
C57/BL/6 (85 mg/20 g mouse), and bone marrow chimeras (115 mg/
20 g mouse). CsA (15 mg/kg) pretreatment was done 1 day prior to
A number of studies have shown that tumors and SEB and then every day up to the final time point.
tumor lines from a variety of tissues express FasL
Functional Assay for FasL Expression(Hahne et al., 1996; O'Connell et al., 1996; Gratas et al.,
FasL function was detected by the ability of IEC or splenocytes to1997; Niehans et al., 1997; Shiraki et al., 1997), and in
induce DNA fragmentation in Fas-positive target cells (Brunner etsome cases this may function to suppress anti-tumor
al., 1995). Briefly, parenteral L1210 and L1210-Fas cells (Rouvier et
immunity (Hahne et al., 1996). Chemotherapeutic drugs al., 1993) were labeled with 5 mCi/ml [3H]thymidine for 4 hr. After
induce FasL expression in some lymphoid and non- incubation cells were rinsed twice with HBSS to remove unincorpo-
rated thymidine. Target cells were then incubated in complete me-lymphoid lines (Friesen et al., 1996; Kasibhatla et al.,
dium with dissociated epithelial cells from the small intestine of1998), and this can be responsible for maximal apopto-
control or treated mice in 96-well plates or with splenocytes in anti-sis in response to these agents. Our results suggest that
CD3-coated 96-well plates. After 18 hr DNA was harvested by MASHsuch nonlymphoid FasL expression may be a reflection
and counted in a b counter. DNA fragmentation was determined as
of a normal physiological role for this molecule in regu- (average counts per control target well 2 counts per experimental
lating immune responses. well)/(average counts per control target well) 3 100. Assays were
performed in triplicate.While our studies focus on the role of peripheral FasL
Immunity
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Assessment of Peripheral Deletion in Vivo After rinsing twice with PBS, cells were fixed in PBS and 1% formal-
dehyde, and staining was assessed by FACScan. An isotype-Fresh blood was obtained from each mouse every second day from
the intraorbital sinus. After rinsing the blood with PBS containing matched control antibody served to define background values.
50 U/ml heparin and 2% FCS, peripheral lymphocytes were isolated
by centrifugation through ficoll Histopaque (density 1.007 g/ml). Isolation of IEC
Peripheral blood mononuclear cells were incubated for 30 min with Mouse small intestine was filleted longitudinally and briefly washed
the following three antibodies: FITC-anti Vb81 and Vb61 (1:100, in HBSS. The tissue was then cut into 1 cm pieces and placed into
Pharmigen), PE-anti-CD41 (1:100, Pharmigen), and RED-613-anti- a conical tube containing 25 cc of RPMI 1640 medium with 10%
CD81 (1:100, GIBCO). After rinsing, surface expression of the corre- fetal calf serum, penicillin (100 U/ml), streptomycin 100 mg/ml, and
sponding proteins was assessed by FACScan flow cytometer (Bec- 1 mM DTT. The tube was shaken at 378C in an orbital shaker for 30
ton Dickinson) as previously described (Mogil et al., 1995). min. The supernatant was filtered through cotton gauze, and cells
were washed once with RPMI 1640 medium. Cells were then resus-
Bone Marrow Chimeras pended in 5 cc of 30% Percoll and centrifuged for 20 min at 400 3
Radiation bone marrow chimeras were prepared as described g. IEC were isolated from the top layer. Visual inspection by light
(Spangrude et al., 1994). Mice received 1100 R irradiation prior to microscopy revealed that cell viability by trypan blue exclusion was
receiving 1 3 107 bone marrow cells. The dose of 1100 R was used over 95%, and over 97% of live cells were IEC. Less than 1% of the
since we had previously determined that this dose permitted the isolated cells were CD31 by flow cytometry.
establishment of fully allogeneic bone marrow chimeras in C57BL/
6 mice. In control experiments using Thy-1 congenic animals, we Lymphocyte Reconstitution in SCID Mice
found that .95% of T cells were derived from the gld or wt grafts C3HSmn.CPrkdeSCID mice were injected i.p. with 4±5 3 107 spleno-
(Griffith et al., 1995). Donor bone marrow cells were isolated on ficoll cytes from C3H or C3H.gld mice. After 48 hr, SCID were challenged
gradients, washed twice with Hanks' balanced salt solution (HBSS), with SEB (75 mg/20 g mouse). Peripheral deletion, IEC induced kill-
and injected (5 3 106/mouse) into the irradiated host. Bone marrow ing, and in situ hybridization were assessed at the established time
chimeras were composed of FasL-defective gld/gld bone marrow points as explained above.
in wt recipient mice (gld→wt) or wt bone marrow in gld recipient
mice (wt→gld). FasL is functional on transplanted lymphoid cells T Cell Preparation and Assessment of Cell Death
but not on nonlymphoid organs in C57BL/6J→B6.gld chimeras and Spleen cells were prepared from 6- to 10-week-old C57BL/6 mice
vice versa for C57BL/6J.gld→C57BL/6J. by passage through a nylon wool column (Julius et al., 1973). Primary
activation was carried out by treating these T cell preparations (1 3
RT±PCR 105 cells/ml) in RPMI, 10% FCS, and penicillin/streptomycin with 2
Total RNA was isolated from mouse organs using TRIzol reagent ng/ml PMA and 1 mg/ml ionomycin for 2 days. Blast cells were then
(GIBCO BRL). cDNA was first prepared by reverse transcription of washed and resuspended in RPMI complete medium with 10 mg/
1 mg RNA in a 20 ml reaction volume containing 103 PCR buffer, 1 ml IL-2.
mM DTT, 200 mM dNTPs, 5 mM random primers (Superscript reverse Cell death was assessed by fluorescent microscopy, examining
transcriptase, GIBCO BRL). PCR amplifications were performed in cell suspensions within a few minutes of resuspension in propidium
50 ml reaction volume containing 1 mg cDNA, with a master mix iodide (5 mg/ml). A minimum of 200 cells were scored for nuclear
composed of 103 PCR buffer, 1 mM MgCl2, 200 mM dNTPs, Taq fluorescence in each group.
polymerase, and 20 nM of each primer. Primers were as follows:
mouse FasL sense, 59-CAGCAGTGCCACTTCATCTTG-39, antisense, Dextran Inhibition
59-TTCACTCCAGAGATCAGAGCGG-39; b-actin sense, 59-TGGATTC A sterile stock solution of 10% (w/v) dextran (2 3 106 mw, Sigma)
CTGTCGCATCCATGAAAG-39, antisense, 59-TTAAACGCAGCTCAG was prepared in RPMI complete medium to block CTL cytotoxicity
TAACAGTCCG-39. The PCR products were separated by 1.2% aga- by preventing effector±target contact (Martz, 1975). To assess the
rose gel electrophoresis and stained with ethidium bromide. inhibitory effect on activation by immobilized antibodies, lympho-
cytes were allowed to sediment onto anti-CD3-coated wells in nor-
In Situ Hybridization mal medium. Then after 1 hr the dextran-rich medium was added
In situ hybridization was performed as described (Simmons et al., gently to displace the normal medium, which was removed from
1989) with minor modifications. Organs were rinsed in PBS to re- the top of the well.
move blood contamination and quick-frozen in OCT embedding
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